Fund Holdings — Decheng Capital LLC

Total Portfolio Value:
$661.32M
Total Bought:
$0
Total Sold:
$89.94M
Net Transaction:
-$89.94M
Securities
▲▼
SharesValue
Q4 2025
▲▼
Q1 2026
▲▼
Change
▲▼
Q4 2025
▲▼
Q1 2026
▲▼
Weight (%)
▲▼
Change
▲▼
CG Oncology, Inc.(CGON)6,371,6696,371,6690$264.55M$431.23M65.21%+$166.68M
Nuvation Bio Inc.(NUVB)25,954,43925,954,4390$232.55M$111.34M16.84%-$121.21M
Upstream Bio, Inc.(UPB)3,143,0782,724,868-418,210$85.33M$24.52M3.71%-$60.81M
Aclaris Therapeutics, Inc.(ACRS)4,041,7364,041,7360$12.17M$15.16M2.29%+$2.99M
Aardvark Therapeutics Inc3,917,2993,917,2990$51.41M$14.77M2.23%-$36.65M
Lyell Immunopharma, Inc.(LYEL)692,050692,0500$21.30M$13.88M2.10%-$7.42M
Newamsterdam Pharma Co Nv
ORDINARY SHARES
592,057325,057-267,000$20.77M$10.41M1.57%-$10.36M
Arcus Biosciences, Inc.(RCUS)541,559477,819-63,740$12.91M$10.32M1.56%-$2.58M
Revolution Medicines, Inc.(RVMD)200,00093,500-106,500$15.93M$9.09M1.37%-$6.84M
Equillium, Inc.(EQ)4,447,3084,447,3080$6.89M$8.89M1.34%+$2.00M
BeyondSpring Inc.SHS(BYSI)3,800,7023,800,7020$6.20M$6.23M0.94%+$38.0K
Zentalis Pharmaceuticals, Inc.(ZNTL)1,323,3271,323,3270$1.79M$3.10M0.47%+$1.31M
Krystal Biotech, Inc.(KRYS)17,3007,300-10,000$4.27M$1.89M0.29%-$2.38M
Pyxis Oncology, Inc.(PYXS)326,810326,8100$375.8K$477.1K0.07%+$101.3K
Aura Biosciences, Inc.(AURA)360,4830-360,483$1.96M$0—-$1.96M
Crinetics Pharmaceuticals In92,7000-92,700$4.32M$0—-$4.32M
4d Molecular Therapeutics In44,3110-44,311$332.3K$0—-$332.3K
Nuvation Bio Inc.WARRANTS(NUVB)646,0570-646,057$213.2K$0—-$213.2K
Rezolute, Inc.(RZLT)59,9000-59,900$141.4K$0—-$141.4K
Page 1 of 1
Decheng Capital LLC — 13F Holdings — Q1 2026 | TickerTrail